Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2012

View Archived Issues

Herbal flavonoid counteracts alcohol intoxication

Inverseon announces initial indication for INV-102

Researchers at Sanofi prepare novel endothelial lipase inhibitors

Sumagen set to start phase I testing of new HIV vaccine

Merck & Co. presents new GPR119 receptor agonists

Novel insulin-like growth factor 1 receptor antagonists patented by Novartis

Novel muscarinic acetylcholine M1 receptor positive allosteric modulators claimed

Abbott prepares new cannabinoid CB2 receptor ligands

U.S. team reports new method to stabilize proteins for therapeutic use

Boehringer Ingelheim and Vitae Pharmaceuticals patent new 11-beta-HSD1 inhibitors

MediciNova and University of Colorado Boulder collaborate on post-TBI therapy

Pergamum begins phase II DPK-060 trial in outer ear infections

Canadian study finds protein kinase inhibitors have potential to reverse resistance to antibiotics

Omni Bio plans new clinical studies of alpha-1-antitrypsin

DAPTA analogue reduces neuropathic pain in animal models

Vernalis and Servier establish new oncology collaboration

Additional funds support IDRI's work in tuberculosis

Evotec and Harvard University form new alliance

Xenetic Biosciences updates status of SymbioTec acquisition and SIIL arrangements

Idenix launches phase I/II IDX-719 study

Phase III study of elacytarabine delayed by manufacturing issues

LoneStar Heart acquires exclusive worldwide license

Ventana to develop companion diagnostic test for Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...